Concepedia

Maryse Labarre

ML

Statistics

Publications

9

Citations

835

H-Index

9

Active since

1999

Affiliations

AstraZeneca (Canada)(Current)

AstraZeneca (United Kingdom)

Maryse Labarre is an author at AstraZeneca (Canada) specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1999–2009

9

Publications

9

Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs

Paola Lembo, Eric Grazzini, Thierry Groblewski et al. · Nature Neuroscience · 2002 · 383 citations

, , +15

Design, Synthesis, and Evaluation of Phe-Gly Mimetics:  Heterocyclic Building Blocks for Pseudopeptides

Susanna Borg, Roeland C. Vollinga, Maryse Labarre et al. · Journal of Medicinal Chemistry · 1999 · 148 citations · Full text

, , +17

New Diarylmethylpiperazines as Potent and Selective Nonpeptidic δ Opioid Receptor Agonists with Increased In Vitro Metabolic Stability

Niklas Plobeck, Daniel Delorme, Zhongyong Wei et al. · Journal of Medicinal Chemistry · 2000 · 116 citations · Full text

, , +17

<i>N,N</i>-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide:  A Novel, Exceptionally Selective, Potent δ Opioid Receptor Agonist with Oral Bioavailability and Its Analogues

Zhongyong Wei, W. A. Brown, Bryan K. Takasaki et al. · Journal of Medicinal Chemistry · 2000 · 82 citations · Full text

, , +17

Inverse agonism by Dmt–Tic analogues and HS 378, a naltrindole analogue

Maryse Labarre, Joanne Butterworth, Stéphane St-Onge et al. · European Journal of Pharmacology · 2000 · 35 citations

, , +7

1–5 of 9